PT  - JOURNAL ARTICLE
AU  - Han, Linxi
AU  - Deng, Qiqi
AU  - He, Zhangyi
AU  - Yu, Feng
TI  - LiMAP-curvature: a simple model-free approach for analysing dose-finding studies
AID  - 10.1101/2022.10.30.22281725
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2022.10.30.22281725
4099  - http://medrxiv.org/content/early/2024/06/05/2022.10.30.22281725.short
4100  - http://medrxiv.org/content/early/2024/06/05/2022.10.30.22281725.full
AB  - MCP-Mod (Multiple Comparison Procedure-Modelling) is an efficient statistical method for the analysis of Phase II dose-finding trials, although it requires specialised expertise to pre-specify plausible candidate models along with model parameters. This can be problematic given limited knowledge of the agent/compound being studied, and misspecification of candidate models and model parameters can severely degrade its performance. To circumvent this challenge, in the work, we introduce LiMAP-curvature, a Bayesian model-free approach for the detection of the dose-response signal in Phase II dose-finding trials. LiMAP-curvature is built upon a Bayesian hierarchical framework incorporating information about the total curvature of the dose-response curve. Through extensive simulations, we show that LiMAP-curvature has comparable performance to MCP-Mod if the true underlying dose-response model is included in the candidate model set of MCP-Mod. Otherwise, LiMAP-curvature can achieve performance superior to that of MCP-Mod, especially when the true dose-response model drastically deviates from candidate models in MCP-Mod.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are simulated.